These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1131 related articles for article (PubMed ID: 19224838)
1. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. Altekruse SF; McGlynn KA; Reichman ME J Clin Oncol; 2009 Mar; 27(9):1485-91. PubMed ID: 19224838 [TBL] [Abstract][Full Text] [Related]
2. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States. Altekruse SF; Henley SJ; Cucinelli JE; McGlynn KA Am J Gastroenterol; 2014 Apr; 109(4):542-53. PubMed ID: 24513805 [TBL] [Abstract][Full Text] [Related]
3. Hepatocellular Carcinoma Incidence Is Decreasing Among Younger Adults in the United States. Rich NE; Yopp AC; Singal AG; Murphy CC Clin Gastroenterol Hepatol; 2020 Jan; 18(1):242-248.e5. PubMed ID: 31042582 [TBL] [Abstract][Full Text] [Related]
4. Epidemiology of hepatocellular carcinoma in Hispanics in the United States. El-Serag HB; Lau M; Eschbach K; Davila J; Goodwin J Arch Intern Med; 2007 Oct; 167(18):1983-9. PubMed ID: 17923599 [TBL] [Abstract][Full Text] [Related]
5. Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992-2018. Alvarez CS; Petrick JL; Parisi D; McMahon BJ; Graubard BI; McGlynn KA Hepatology; 2022 Sep; 76(3):589-598. PubMed ID: 35124828 [TBL] [Abstract][Full Text] [Related]
6. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States. Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481 [TBL] [Abstract][Full Text] [Related]
7. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma. Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289 [TBL] [Abstract][Full Text] [Related]
8. Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012. White DL; Thrift AP; Kanwal F; Davila J; El-Serag HB Gastroenterology; 2017 Mar; 152(4):812-820.e5. PubMed ID: 27889576 [TBL] [Abstract][Full Text] [Related]
9. Socioeconomic status and hepatocellular carcinoma in the United States. Shebl FM; Capo-Ramos DE; Graubard BI; McGlynn KA; Altekruse SF Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1330-5. PubMed ID: 22669949 [TBL] [Abstract][Full Text] [Related]
10. State-Level HCC Incidence and Association With Obesity and Physical Activity in the United States. Lee YT; Wang JJ; Luu M; Tseng HR; Rich NE; Lu SC; Nissen NN; Noureddin M; Singal AG; Yang JD Hepatology; 2021 Sep; 74(3):1384-1394. PubMed ID: 33728665 [TBL] [Abstract][Full Text] [Related]
11. Disparities in Hepatocellular Carcinoma Incidence, Stage, and Survival: A Large Population-Based Study. Flores YN; Datta GD; Yang L; Corona E; Devineni D; Glenn BA; Bastani R; May FP Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1193-1199. PubMed ID: 33737301 [TBL] [Abstract][Full Text] [Related]
12. Sex and Race Disparities in the Incidence of Hepatocellular Carcinoma in the United States Examined through Age-Period-Cohort Analysis. Zhang X; El-Serag HB; Thrift AP Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):88-94. PubMed ID: 31712271 [TBL] [Abstract][Full Text] [Related]
13. Disparities in hepatocellular carcinoma incidence by race/ethnicity and geographic area in California: Implications for prevention. Yang B; Liu JB; So SK; Han SS; Wang SS; Hertz A; Shariff-Marco S; Lin Gomez S; Rosenberg PS; Nguyen MH; Hsing AW Cancer; 2018 Sep; 124(17):3551-3559. PubMed ID: 30113700 [TBL] [Abstract][Full Text] [Related]
14. Changing Landscape of Liver Cancer in California: A Glimpse Into the Future of Liver Cancer in the United States. Han SS; Kelly SP; Li Y; Yang B; Nguyen M; So S; Rosenberg PS; Hsing AW J Natl Cancer Inst; 2019 Jun; 111(6):550-556. PubMed ID: 30544184 [TBL] [Abstract][Full Text] [Related]
15. Risk factors associated with suicide among hepatocellular carcinoma patients: A surveillance, epidemiology, and end results analysis. Chen C; Jiang Y; Yang F; Cai Q; Liu J; Wu Y; Lin H Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):640-648. PubMed ID: 33051117 [TBL] [Abstract][Full Text] [Related]
16. Cohort Contributions to Race- and Gender-Specific Trends in the Incidence of Hepatocellular Carcinoma in the USA. Beal EW; Tumin D; Kabir A; Moris D; Zhang XF; Chakedis J; Washburn K; Black S; Schmidt CM; Pawlik TM World J Surg; 2018 Mar; 42(3):835-840. PubMed ID: 28879603 [TBL] [Abstract][Full Text] [Related]
17. Racial Disparities and Sociodemographic Differences in Incidence and Survival Among Pediatric Patients in the United States With Primary Liver Cancer: A Surveillance, Epidemiology, and End Results (SEER) Population Study. Nautsch F; Ludwig JM; Xing M; Johnson KM; Kim HS J Clin Gastroenterol; 2018 Mar; 52(3):262-267. PubMed ID: 28617762 [TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma - United States, 2001-2006. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2010 May; 59(17):517-20. PubMed ID: 20448528 [TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma: recent trends in the United States. El-Serag HB Gastroenterology; 2004 Nov; 127(5 Suppl 1):S27-34. PubMed ID: 15508094 [TBL] [Abstract][Full Text] [Related]
20. Racial and Geographic Disparities in Hepatocellular Carcinoma Outcomes. Franco RA; Fan Y; Jarosek S; Bae S; Galbraith J Am J Prev Med; 2018 Nov; 55(5 Suppl 1):S40-S48. PubMed ID: 30670200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]